newsGP – Peptide use ‘emerging faster than we’re tracking it’ – Royal Australian College of General Practitioners (RACGP)
newsGP – Peptide use ‘emerging faster than we’re tracking it’ Royal Australian College of General Practitioners (RACGP)
Improving Cognition in Bipolar Disorder: A Systematic Review of Current Pharmacological and Nutraceutical Approaches.
This systematic review examined pharmacological and nutraceutical interventions aimed at improving cognitive impairment in bipolar disorder patients. The review synthesized evidence on various treatment approaches, including methylene blue among other compounds, to identify current strategies for addressing cognitive dysfunction in this population. Evidence level: Review of human clinical and related studies.
Pretreatment With Methylene Blue Atenuates Seizures, Cognitive Impairment, Hippocampal Neuronal Damage and Oxidative Stress in Pentylenetetrazole-Kindled Rats.
This animal model study investigated whether pretreatment with methylene blue could reduce seizures and associated brain damage in rats subjected to repeated seizure induction via pentylenetetrazole. Researchers found that methylene blue pretreatment attenuated seizure severity, prevented cognitive impairment, reduced hippocampal neuronal damage, and decreased oxidative stress markers compared to untreated seizure-prone rats. This is an animal model study with potential translational relevance, though findings require further investigation in human clinical populations before any clinical applications can be considered.
Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in Rats.
This review article examines the potential therapeutic role of BPC 157, a 15-amino acid peptide, in treating severe electrolyte disturbances in rats (animal model evidence). The review synthesizes findings demonstrating that BPC 157 administration was associated with improvements in electrolyte balance and related physiological parameters in rat studies. The evidence presented is limited to animal model research and represents a summary of existing literature rather than new primary research findings.
Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of BPC 157 and Related Therapeutics.
This review article examines how BPC 157, a synthetic peptide derived from gastric juice, may provide cytoprotective effects that could theoretically address both hemorrhagic and thrombotic conditions through a unified mechanism (evidence level: review of human clinical, animal model, and in vitro studies). The authors synthesize existing literature suggesting BPC 157 promotes cellular protective mechanisms and vascular homeostasis, though the specific pathways and clinical applicability remain largely supported by preclinical evidence rather than robust human trials. The review highlights the potential therapeutic relevance of cytoprotective strategies but does not establish definitive clinical efficacy in human hemorrhage or thrombosis management.
Effects of Nicotinamide Mononucleotide Supplementation on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
This systematic review and meta-analysis examined randomized controlled trials investigating nicotinamide mononucleotide (NMN) supplementation and its effects on blood pressure outcomes. The analysis synthesized data from human clinical trials to evaluate whether NMN supplementation produces measurable changes in systolic and diastolic blood pressure readings. This evidence represents a human clinical level of evidence derived from aggregated randomized controlled trial data.
RFK, Jr. getting heat from MAHA for bowing to Trump and ‘abandoning’ anti-vaccine dogma – Genetic Literacy Project
RFK, Jr. getting heat from MAHA for bowing to Trump and ‘abandoning’ anti-vaccine dogma Genetic Literacy Project
The patient’s guide to peptide therapies in the age of GLP-1s – Nonstop Local News
The patient’s guide to peptide therapies in the age of GLP-1s Nonstop Local News
The patient’s guide to peptide therapies in the age of GLP-1s – Nonstop Local News Read Post »
RFK, Jr. is wrong—measles do not boost your immune system – Genetic Literacy Project
RFK, Jr. is wrong—measles do not boost your immune system Genetic Literacy Project
RFK, Jr. is wrong—measles do not boost your immune system – Genetic Literacy Project Read Post »
Atypical population pharmacokinetics of hydromethylthionine in patients with Alzheimer’s disease explains unexpected phase 3 trial results.
This study examined how methylene blue (hydromethylthionine) is processed in the body when given orally to Alzheimer’s patients versus healthy people. The researchers found that Alzheimer’s patients process the drug differently than expected, which helps explain why previous clinical trials had unexpected results. The drug targets tau protein clumps in the brain that contribute to Alzheimer’s disease and also has other brain benefits.
Aging Triggers an Intestinal Energy Crisis and HDL3 Deficiency Disrupting Gut-Liver Axis Homeostasis.
This study found that aging causes an energy crisis in the intestines that disrupts production of HDL3, a beneficial cholesterol that protects the liver from inflammation. Supplementing with NMN restored intestinal energy production and HDL3 levels, which helped reduce liver damage and inflammation associated with aging. The research suggests NMN may help maintain healthy gut-liver communication as we age.
Development of Freeze-Dried Hyaluronic Acid Sheets for Healing Oral Mucositis: Influence of Hyaluronic Acid Molecular Weight and Nicotinamide Mononucleotide Loading on Healing Efficacy.
Researchers tested different formulations of hyaluronic acid sheets loaded with NMN to treat severe mouth sores that occur during cancer treatment. They found that 800 kDa hyaluronic acid sheets provided the best healing results in animal studies. The NMN-loaded sheets stayed in place well and released the compound steadily, showing promise as a safe treatment for painful mouth ulcers in cancer patients.